Furosemide (Furosemide)



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 18.2%
Drug Use For Unknown Indication 13.6%
Hypertension 13.6%
Asthma 9.1%
Atrial Fibrillation 9.1%
Anxiety 4.5%
Chronic Obstructive Pulmonary Disease 4.5%
Oedema 4.5%
Osteoporosis 4.5%
Peripheral Oedema 4.5%
Pulmonary Hypertension 4.5%
Right Ventricular Failure 4.5%
Urinary Tract Infection 4.5%
Renal Failure Acute 23.1%
Gastrointestinal Tract Mucosal Pigmentation 7.7%
Hepatitis 7.7%
Medication Error 7.7%
Post Procedural Complication 7.7%
Presyncope 7.7%
Spinal Epidural Haematoma 7.7%
Tinnitus 7.7%
Tricuspid Valve Incompetence 7.7%
Ventricular Dysfunction 7.7%
Ventricular Tachycardia 7.7%
Secondary
Product Used For Unknown Indication 65.9%
Hypertension 7.2%
Drug Use For Unknown Indication 4.4%
Hypertension Arterial 3.4%
Type 2 Diabetes Mellitus 2.8%
Cardiac Failure 1.9%
Hypertension Arterial 1.6%
Depression 1.6%
Urinary Tract Infection 1.6%
Abnormal Behaviour 1.3%
Cardiac Disorder 1.3%
Dyslipidaemia 1.3%
Pain 1.3%
Hypertension 0.9%
Arrhythmia 0.6%
Ascites 0.6%
Blood Pressure 0.6%
Chronic Ischemic Heart Disease, Unspecified 0.6%
Oedema 0.6%
Osteomyelitis 0.6%
Renal Failure Acute 18.2%
Toxicity To Various Agents 12.7%
Syncope 9.1%
Presyncope 7.3%
Rhabdomyolysis 5.5%
Thrombocytopenia 5.5%
Vomiting 5.5%
Angioedema 3.6%
Dehydration 3.6%
Overdose 3.6%
Premature Delivery 3.6%
Stevens-johnson Syndrome 3.6%
Toxic Epidermal Necrolysis 3.6%
Weight Loss Poor 3.6%
Cheilitis 1.8%
Disturbance In Attention 1.8%
Dysstasia 1.8%
Hypokalaemia 1.8%
Hypomagnesaemia 1.8%
Inappropriate Antidiuretic Hormone Secretion 1.8%
Concomitant
Product Used For Unknown Indication 24.1%
Plasma Cell Myeloma 14.7%
Type 2 Diabetes Mellitus 9.5%
Hypertension 6.9%
Osteoporosis 5.2%
Drug Use For Unknown Indication 3.5%
Atrial Fibrillation 3.3%
Chronic Myeloid Leukaemia 3.3%
Multiple Myeloma 3.1%
Myelodysplastic Syndrome 3.1%
Prophylaxis 3.1%
Depression 2.8%
Immunodeficiency Common Variable 2.8%
Prostate Cancer Metastatic 2.6%
Parkinson's Disease 2.4%
Nuclear Magnetic Resonance Imaging 2.1%
Chronic Lymphocytic Leukaemia 1.9%
Colorectal Cancer Metastatic 1.9%
Diabetes Mellitus 1.9%
Pulmonary Arterial Hypertension 1.9%
Vomiting 11.5%
Renal Failure Acute 9.7%
Pneumonia 7.9%
Thrombocytopenia 6.1%
Weight Decreased 6.1%
Oedema Peripheral 4.8%
Renal Failure Chronic 4.8%
Tremor 4.8%
Rash 4.2%
Sepsis 4.2%
Toxicity To Various Agents 4.2%
White Blood Cell Count Decreased 4.2%
Platelet Count Decreased 3.6%
Tachycardia 3.6%
Treatment Failure 3.6%
Urticaria 3.6%
Weight Increased 3.6%
Death 3.0%
International Normalised Ratio Increased 3.0%
Pancreatitis 3.0%